Investigators at the Minneapolis VA Health Care System and the University of Minnesota found that “watchful waiting” or prostate specific antigen (PSA) monitoring may be the best approach for many men with prostate cancer. While practicing watchful waiting may slightly increase risk of death for some men clinically diagnosed with cancer, it reduces harm, compared to surgery. The findings will potentially help improve health care quality and inform clinical practice guidelines.

The results suggest that surgery for prostate cancer may be necessary only for younger patients and those with more aggressive cancers, according to lead study author Dr. Timothy Wilt, of the Minneapolis VA Center for Care Delivery and Outcomes Research, and the Minnesota Agency for Healthcare Research and Quality Evidence-based Practice Center.

“I hope that clinical guidelines incorporate this information and find a broader role for watchful waiting and PSA-based testing for most men,” noted Wilt.

The results appeared in the Dec. 22, 2020, issue of the Journal of Urology.

Most men with prostate cancer do not die from it

After skin cancer, prostate cancer is the most-diagnosed form of cancer for men in the United States. It is the second leading cause of cancer death in U.S. men.

However, most cases grow slowly and do not cause symptoms, even if untreated. About 90% of cases are localized, meaning that the cancer is confined to the prostate gland and may not spread to other parts of the body. This is especially true in men diagnosed currently by blood testing for PSA.

The vast majority of men with prostate cancer (90%) do not die from it.

Despite the fact that prostate cancer is often slow-growing, many patients and doctors opt for an aggressive approach to care, such as surgery or radiation, which can result in urinary, sexual and bowel problems. Radical prostatectomy – surgery to remove the prostate gland – is the most common treatment for prostate cancer. An alternative is watchful waiting, in which direct treatment is deferred while patients are monitored for symptom changes and possible cancer spread.

Studies find varying levels of risk

The researchers conducted a systematic review of 67 studies to compare the effectiveness of watchful waiting versus radical prostatectomy, along with several other treatments. The review is one of the first studies to look at very long-term results.

The results showed that watchful waiting may increase the risk of both the spread of cancer and death from cancer, compared with surgery, in men with clinically detected cancer. Importantly, the studies comparing the two treatments were long-term studies, looking at results over 20 years, begun before PSA testing became common. Clinical detection of prostate cancer relies on physical examination and biopsy. PSA testing, on the other hand, can detect cancer earlier and find smaller, slower-growing tumors. PSA testing is able to diagnose prostate cancer up to five years or so before it would be clinically detectable.

Different studies reviewed found varying levels of risk: overall, after 20 to 25 years, watchful waiting was linked to an increase in death from any cause of 5% to 15%, and an increase in cancer-related death of 4% to 10%. However, patients undergoing watchful waiting had lower rates of urinary and erectile dysfunction than those who underwent radical prostatectomy.

Share this story

Published on Apr. 2, 2021

Estimated reading time is 2.6 min.

Views to date: 408


  1. Nathan Jackson April 11, 2021 at 3:24 pm

    Wow you actually got some one to talk to you about it, and surgery!!! Amazing!! I get nothing. I figured they will wait as long as possible so I’m sure to die. Then drag things out while making it look like the VA is trying. Ever noticed the Friday evening calls that requires something you can’t do until Monday. Or the phone no one answers. My favorite, the unmarked doors where the real medical is. They refused to fix a twist in my large intestine for 17 years. Just a simple colonoscopy for a Army injury. I don’t have a large intestine any more. I have cancer and disease all over and no information or anyone who will tell me anything. $700 a month for private medical and they wrote (Go To The VA). I’m so stupid I thought the VA would be mad about veterans being ripped off.

  2. Conrad Cool April 7, 2021 at 7:34 pm

    Most men with prostate cancer do not die from it.
    After skin cancer, prostate cancer is the most-diagnosed form of cancer for men in the United States. It is the second leading cause of cancer death in U.S. men.
    Seems to me that these are two conflicting statements.

  3. jerry lee whitson April 7, 2021 at 7:32 pm

    i had surgery and radiation 13 years ago and psa is neg. i am glad i did

  4. Eric Anthony April 7, 2021 at 6:26 pm

    The article does not address two other liabilities of prostate cancer treatment: the “standard of care” biopsy and prostatectomy seeding cancer cells resulting in recurrent prostate cancer. With the biopsy 12 needles perforate three organs: if they hit the suspected cancer, they pull cancer cells back through all intervening tissue spreading the cancer, which typically shows up about a year later in the PSA — a truly medieval, bloody and dangerous procedure which should be abolished. I am not saying don’t get diagnosed; but that with the advances in imaging there are less invasive ways to do it. Surgical prostatectomy likewise has this liability because the surgeon cannot see microscopically to be sure he has removed all the cancer cells. Therefore, after the surgery your PSA will be tested about every 6 months because any rise in it (above the .001 level) indicates recurrent cancer. I would like to see the VA publish the statistics on how many cases of post/surgery recurrent prostate cancer they actually have in patients within five years after the procedure?

  5. C Herr April 3, 2021 at 8:09 pm

    A masters in writing and you are giving medical advice. Please… that is just irresponsible. Prostate cancer kills people. If you are dead, none of the side effects much matter. The key is to talk to doctors at the top of their game and make an informed choice.

Comments are closed.

More Stories

  • New genetic research discoveries may one day help doctors better screen Veterans at risk of suicide and prevent it in the first place.

  • Greg Amira, Purple Heart Iraq Veteran and 9/11 survivor, became the 900,000th Veteran to join the Million Veteran Program.

  • A VA study has found that Pharmacogenomic, or genetic testing, can help providers avoid prescribing antidepressant medications that may have undesirable outcomes.